81246 Flt3 gene analysis
Also known as: FLT3 comprehensive analysis, FLT3 full gene testing
Comprehensive molecular analysis of the FLT3 gene to detect various mutations and rearrangements in acute myeloid leukemia.
In Plain Language
acute leukemia gene test; blood cancer genetic analysis
Clinical Context
Used for comprehensive FLT3 mutation screening in acute myeloid leukemia for complete prognostic assessment and treatment planning.
RVU Information
CPT 81246 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81246?
CPT 81246 (Flt3 gene analysis) is a Pathology & Lab code. Comprehensive molecular analysis of the FLT3 gene to detect various mutations and rearrangements in acute myeloid leukemia.
Who uses CPT code 81246?
CPT 81246 is used by Hematology, Oncology, Pathology. Used for comprehensive FLT3 mutation screening in acute myeloid leukemia for complete prognostic assessment and treatment planning.
When is CPT 81246 used?
Used for comprehensive FLT3 mutation screening in acute myeloid leukemia for complete prognostic assessment and treatment planning.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.